Adding blinatumomab to chemotherapy reduces recurrence risk in standard-risk paediatric B-ALL
Nature Reviews Clinical Oncology – Adding blinatumomab to chemotherapy reduces recurrence risk in standard-risk paediatric B-ALL
Related Articles
Registration
Register for the AACR Annual Meeting 2025, taking place April 25-30 in Chicago, Illinois.
Nivolumab Plus Ipilimumab Wins European Approval for MSI-H/dMMR mCRC
Nivolumab plus ipilimumab has been approved in Europe for the frontline treatment of adult patients with MSI-H or dMMR metastatic colorectal cancer.
FDA Grants NX-5948 Fast Track Designation in R/R Waldenström Macroglobulinemia
The FDA granted fast track designation to NX-5948 for treating relapsed/refractory Waldenström macroglobulinemia after 2 or more lines of therapy, including a BTK inhibitor.
Abstracts – 2025 ASTRO Annual Meeting – American Society for Radiation Oncology (ASTRO)
The Annual Meeting program will deliver the top science and education related to the field of radiation oncology.
APCCC Diagnostics 2025 – APCCC
The diagnostic abilities for assessing prostate cancer patients have significantly evolved in the last years. Ranging from advanced imaging modalities for detection, new innovative liquid…
Spreading Joy through Giving: Supporting the Community Angel Tree Program
A dedicated Moffitt team works to bringing Christmas magic to foster children in Hillsborough County
FDA Grants Priority Review to Taletrectinib in ROS1+ Advanced NSCLC
The FDA has granted priority review to the NDA seeking the approval for taletrectinib in ROS1-positive advanced non–small cell lung cancer.
AACR-Sontag Foundation Brain Cancer Research Fellowship
The fellowship provides a two-year grant of $130,000 to support the salary and benefits of the fellow while working on a mentored brain cancer research…
The day the National Cancer Act became law
Speeches, footage, and dispatches from Dec. 23, 1971 Fifty years ago, President Nixon interrupted Christmas festivities to sign the National Cancer Act of 1971 into…
High5 Oncology TV: SABCS 2024
Für den erfolgreichen Abschluss der Fortbildungsmodule ist die korrekte (mind. 70%) Beantwortung der Lernerfolgskontrolle für das jeweilige Modul verpflichtend. Jetzt gleich den Fragebogen ausfüllen! Durch…